A detailed history of Benjamin F. Edwards & Company, Inc. transactions in National Research Corp stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 2,783 shares of NRC stock, worth $54,212. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,783
Previous 1,133 145.63%
Holding current value
$54,212
Previous $45,000 42.22%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$22.95 - $39.34 $37,867 - $64,911
1,650 Added 145.63%
2,783 $64,000
Q1 2024

Apr 29, 2024

BUY
$36.87 - $41.2 $37,423 - $41,818
1,015 Added 860.17%
1,133 $45,000
Q4 2023

Feb 06, 2024

SELL
$39.05 - $46.39 $3,006 - $3,572
-77 Reduced 39.49%
118 $5,000
Q3 2023

Nov 13, 2023

SELL
$41.8 - $46.78 $710 - $795
-17 Reduced 8.02%
195 $9,000
Q2 2023

Aug 15, 2023

SELL
$40.78 - $46.7 $2,650 - $3,035
-65 Reduced 23.47%
212 $9,000
Q1 2023

Apr 27, 2023

SELL
$38.17 - $47.17 $4,618 - $5,707
-121 Reduced 30.4%
277 $12,000
Q4 2022

Feb 07, 2023

SELL
$35.23 - $41.21 $2,113 - $2,472
-60 Reduced 13.1%
398 $15,000
Q2 2022

Aug 12, 2022

SELL
$31.87 - $40.9 $1,179 - $1,513
-37 Reduced 7.47%
458 $18,000
Q1 2022

May 04, 2022

SELL
$36.33 - $42.25 $2,506 - $2,915
-69 Reduced 12.23%
495 $20,000
Q4 2021

Feb 07, 2022

SELL
$40.05 - $49.0 $13,657 - $16,709
-341 Reduced 37.68%
564 $23,000
Q3 2021

Nov 02, 2021

BUY
$42.17 - $54.5 $38,163 - $49,322
905 New
905 $38,000
Q2 2020

Aug 14, 2020

SELL
$42.29 - $59.2 $17,042 - $23,857
-403 Closed
0 $0
Q1 2020

May 07, 2020

BUY
$35.01 - $70.35 $7,527 - $15,125
215 Added 114.36%
403 $18,000
Q4 2019

Feb 06, 2020

BUY
$55.77 - $67.47 $10,484 - $12,684
188 New
188 $12,000

Others Institutions Holding NRC

About NATIONAL RESEARCH CORP


  • Ticker NRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 24,767,100
  • Market Cap $482M
  • Description
  • National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-re...
More about NRC
Track This Portfolio

Track Benjamin F. Edwards & Company, Inc. Portfolio

Follow Benjamin F. Edwards & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.